Pieris Pharmaceuticals Reports Full-Year 2020 Financial Results and Provides Corporate Update,

The global phase 2a study of PRS-060/AZD1402 is a two-part, multi-center, placebo-controlled clinical study that will evaluate the drug candidate at …, The global phase 2a study of PRS-060/AZD1402 is a two-part, multi-center, placebo-controlled clinical study that will evaluate the drug candidate at …, Read More

Scroll to Top